The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-02. Anything still debated is marked as such rather than presented as settled.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
== Regulation == Some of the strategies for regulating retinal dehydrogenases are only now becoming more clear after in vivo regulation remained mysterious for some time, though much of the current research on regulation has focused on the modulation of gene expression rather than direct protein regulation. Dendritic cells in the gut help in modulating immune tolerance through the activity of retinal dehydrogenase; expression in these cells may be driven by a TNF receptor, 4-1-BB. It was also shown that the expression of a certain retinal dehydrogenase found in humans, retinal short-chain dehydrogenase/reductase (retSDR1), is increased by tumor-suppressor proteins p53 and p63, suggesting that retSDR1 may have tumor-preventing activities. Expression of retinal dehydrogenase types 1 and 2 genes is enhanced by the addition of cholesterol or cholesterol derivatives. Disulfiram is a drug used to artificially regulate aldehyde dehydrogenase activity in patients with alcoholism by inhibiting the activity of aldehyde dehydrogenases, though it is not specific to retinal dehydrogenase. Other exogenous molecules have also been found to inhibit retinal dehydrogenase activity including nitrofen, 4-biphenyl carboxylic acid, bisdiamine, and SB-210661.
The increasingly repressive policies of the partitioning powers led to resistance movements in partitioned Poland, and in 1830 Polish patriots staged the November Uprising. This revolt developed into a full-scale war with Russia, but the leadership was taken over by Polish conservatives who were reluctant to challenge the empire and hostile to broadening the independence movement's social base through measures such as land reform. Despite the significant resources mobilized, a series of errors by several successive chief commanders appointed by the insurgent Polish National Government led to the defeat of its forces by the Russian army in 1831. Congress Poland lost its constitution and military, but formally remained a separate administrative unit within the Russian Empire.
Christopher Layne claims that the preponderance of power has been the dominant US strategy during both the Cold War and the post-Cold War periods. "Preponderance's strategic imperatives are the same as they were during the post-World War II era: pacification and reassurance in Europe and East Asia, and protection of these regions from instability in the periphery." The post-Cold War strategy of preponderance holds that "only a preponderance of US power ensures peace" which is "the result of an imbalance of power in which US capabilities are sufficient, operating on their own, to cow all potential challengers and to comfort all coalition partners. It is not enough consequently to be primus inter pares [...] One must be primus solus." Layne since the beginning of the post-Cold war period expects the preponderance of power to trigger counterbalancing. He finds that "it was the bipolar structure of the postwar system that allowed Washington to pursue a strategy of preponderance successfully" and thereby smother the emergence of other great powers. But the preponderance of power which "others found merely irritating in a bipolar world may seem quite threatening in a unipolar world." Because of these structural factors, "an American strategy of preponderance [...] is doomed to failure"; it will "cause other states to balance against the United States". Overturning the scholarly conventional wisdom, however, the current preponderant power seems to render inoperative the counterbalancing long central to research in international relations.
Sources: en.wikipedia.org
As Western imports became popular, demand for Japanese art declined within Japan itself. In Europe and America, the new availability of Japanese art led to a fascination for Japanese culture; a craze known in Europe as Japonisme. Imperial patronage, government sponsorship, promotion to new audiences, and Western technology combined to foster an era of Japanese artistic innovation. In the decorative arts, Japanese artists reached new levels of technical sophistication. Today, Masayuki Murata owns more than 10,000 Meiji art works and is one of the most enthusiastic collectors. From that time, most of the excellent works of Meiji Art were bought by foreign collectors and only a few of them remained in Japan, but because he bought back many works from foreign countries and opened the Kiyomizu Sannenzaka Museum, the study and reevaluation of Meiji Art rapidly advanced in Japan from the 21st century. Nasser Khalili is also one of the world's most dedicated collectors of Meiji art, and his collection encompasses many categories of Meiji art. The Japanese Imperial Family also owns excellent works of Meiji Art, some of which were donated to the state and are now stored in the Museum of the Imperial Collections.
Three major genes are involved in determination of Drosophila sex. These are sex-lethal, sisterless, and deadpan. Deadpan is an autosomal gene which inhibits sex-lethal, while sisterless is carried on the X chromosome and inhibits the action of deadpan. An AAX cell has twice as much deadpan as sisterless, so sex-lethal will be inhibited, creating a male. However, an AAXX cell will produce enough sisterless to inhibit the action of deadpan, allowing the sex-lethal gene to be transcribed to create a female. Later, control by deadpan and sisterless disappears and what becomes important is the form of the sex-lethal gene. A secondary promoter causes transcription in both males and females. Analysis of the cDNA has shown that different forms are expressed in males and females. Sex-lethal has been shown to affect the splicing of its own mRNA. In males, the third exon is included which encodes a stop codon, causing a truncated form to be produced. In the female version, the presence of sex-lethal causes this exon to be missed out; the other seven amino acids are produced as a full peptide chain, again giving a difference between males and females. Presence or absence of functional sex-lethal proteins now go on to affect the transcription of another protein known as doublesex. In the absence of sex-lethal, doublesex will have the fourth exon removed and be translated up to and including exon 6 (DSX-M[ale]), while in its presence the fourth exon which encodes a stop codon will produce a truncated version of the protein (DSX-F[emale]).
Transactions typically use Bitcoin for payment, sometimes combined with tumblers for added anonymity and PGP to secure communications between buyers and vendors from being stored on the site itself. Many sites use Bitcoin multisig transactions to improve security and reduce dependency on the site's escrow. The discontinued Helix Bitcoin tumbler offered direct anonymized marketplace payment integrations. On making a purchase, the buyer must transfer cryptocurrency into the site's escrow, after which a vendor dispatches their goods then claims the payment from the site. On receipt or non-receipt of the item users may leave feedback against the vendor's account. Buyers may "finalize early" (FE), releasing funds from escrow to the vendor prior to receiving their goods in order to expedite a transaction, but leave themselves vulnerable to fraud if they choose to do so. Following Operation Onymous, there was a substantial increase in PGP support from vendors, with PGP use on two marketplaces near 90%. This suggests that law enforcement responses to cryptomarkets result in continued security innovations, thereby making markets more resilient to undercover law enforcement efforts.
== D == dactinomycin - dalton - decarboxylation reaction - delta opioid receptor - denaturation (biochemistry) - dendrite - dendritic cell - dendritic spine - deoxyribonucleoprotein - deoxyribose - desmopressin - deuterium - developmental biology - dialysis (chemical) - diffusion - dimer - dinucleotide repeat - diploid - disaccharide - dissociation constant - disulfide bond - disulfide bridge - DNA - DNA fragmentation - DNA replication - DNA sequence - DNA topology - DNA transposable element - DNA virus - DNA-binding protein - dopamine D1 receptor - dopamine D2 receptor - dopamine receptor - double helix - Drosophila - drugs - dynorphin
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.